News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
190,820 Results
Type
Article (4816)
Company Profile (56)
Press Release (185942)
Multimedia
Podcasts (5)
Webinars (7)
Section
Business (52936)
Career Advice (297)
Deals (10759)
Drug Delivery (21)
Drug Development (9025)
Employer Resources (28)
FDA (5236)
Job Trends (4572)
News (80168)
Policy (6093)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (605)
Accelerated approval (3)
Allergies (41)
Alliances (18669)
ALS (29)
Alzheimer's disease (356)
Antibody-drug conjugate (ADC) (41)
Approvals (5413)
Artificial intelligence (296)
Autoimmune disease (24)
Automation (30)
Bankruptcy (67)
Best Places to Work (4212)
BIOSECURE Act (3)
Biosimilars (59)
Biotechnology (41)
Bladder cancer (47)
Brain cancer (11)
Breast cancer (129)
Cancer (970)
Cardiovascular disease (72)
Career advice (267)
Career pathing (10)
CAR-T (42)
CDC (1)
Cell therapy (158)
Cervical cancer (12)
Clinical research (8072)
Collaboration (758)
Compensation (111)
Complete response letters (7)
COVID-19 (523)
CRISPR (35)
C-suite (240)
Cystic fibrosis (11)
Data (1207)
Decentralized trials (2)
Denatured (5)
Depression (29)
Diabetes (110)
Diagnostics (3286)
Digital health (31)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (85)
Drug pricing (27)
Drug shortages (4)
Duchenne muscular dystrophy (13)
Earnings (17935)
Editorial (5)
Employer resources (28)
Events (24526)
Executive appointments (343)
FDA (6333)
Funding (511)
Gene editing (51)
Generative AI (19)
Gene therapy (123)
GLP-1 (158)
Government (762)
Grass and pollen (2)
Guidances (163)
Healthcare (6122)
HIV (29)
Huntington's disease (1)
IgA nephropathy (6)
Immunology and inflammation (14)
Immuno-oncology (9)
Indications (38)
Infectious disease (590)
Inflammatory bowel disease (38)
Inflation Reduction Act (2)
Influenza (31)
Intellectual property (63)
Interviews (39)
IPO (4380)
IRA (5)
Job creations (518)
Job search strategy (213)
JPM (6)
Kidney cancer (1)
Labor market (15)
Layoffs (46)
Leadership (9)
Legal (1062)
Liver cancer (9)
Longevity (5)
Lung cancer (123)
Lymphoma (62)
Machine learning (22)
Management (13)
Manufacturing (355)
MASH (15)
Medical device (7297)
Medtech (7330)
Mergers & acquisitions (6865)
Metabolic disorders (209)
Multiple sclerosis (27)
NASH (1)
Neurodegenerative disease (59)
Neuropsychiatric disorders (8)
Neuroscience (584)
NextGen: Class of 2026 (2418)
Non-profit (1054)
Now hiring (8)
Obesity (75)
Opinion (59)
Ovarian cancer (24)
Pain (85)
Pancreatic cancer (45)
Parkinson's disease (60)
Partnered (17)
Patents (135)
Patient recruitment (114)
Peanut (17)
People (14607)
Pharmaceutical (12)
Pharmacy benefit managers (8)
Phase 1 (1894)
Phase 2 (3057)
Phase 3 (3528)
Pipeline (1433)
Policy (30)
Postmarket research (372)
Preclinical (854)
Press Release (21)
Prostate cancer (55)
Psychedelics (4)
Radiopharmaceuticals (72)
Rare diseases (143)
Real estate (1736)
Recruiting (8)
Regulatory (5407)
Reports (13)
Research institute (638)
Resumes & cover letters (47)
Rett syndrome (7)
RNA editing (3)
RSV (14)
Schizophrenia (14)
Series A (84)
Series B (65)
Service/supplier (6)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (16)
Sponsored (23)
Startups (821)
State (1)
Supply chain (50)
Tariffs (6)
Vaccines (171)
Venture capital (12)
Weight loss (45)
Women's health (42)
Worklife (4)
Date
Last 7 days (181)
Last 30 days (646)
Last 365 days (8229)
2026 (848)
2025 (8530)
2024 (10451)
2023 (11597)
2022 (17446)
2021 (18606)
2020 (18708)
2019 (16612)
2018 (11950)
2017 (9321)
2016 (8691)
2015 (9523)
2014 (6978)
2013 (5946)
2012 (6300)
2011 (6059)
2010 (4859)
Location
Africa (151)
Alabama (22)
Alaska (2)
Arizona (88)
Arkansas (4)
Asia (10028)
Australia (1202)
California (2796)
Canada (932)
China (249)
Colorado (195)
Connecticut (111)
Delaware (132)
Europe (25989)
Florida (503)
Georgia (166)
Hawaii (2)
Idaho (43)
Illinois (409)
India (39)
Indiana (323)
Iowa (9)
Japan (130)
Kansas (35)
Kentucky (13)
Louisiana (9)
Maine (29)
Maryland (324)
Massachusetts (1593)
Michigan (173)
Minnesota (326)
Mississippi (5)
Missouri (74)
Montana (19)
Nebraska (12)
Nevada (41)
New Hampshire (49)
New Jersey (957)
New Mexico (17)
New York (614)
North Carolina (636)
North Dakota (8)
Northern California (1244)
Ohio (152)
Oklahoma (10)
Oregon (17)
Pennsylvania (630)
Puerto Rico (4)
Rhode Island (25)
South America (294)
South Carolina (51)
South Dakota (1)
Southern California (1091)
Tennessee (63)
Texas (477)
United States (11234)
Utah (101)
Vermont (1)
Virginia (75)
Washington D.C. (20)
Washington State (174)
West Virginia (2)
Wisconsin (89)
Wyoming (1)
190,820 Results for "pmd solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OMEICOS Therapeutics Announces Positive Phase 2 Study Outcome Demonstrating OMT-28’s Potential in Primary Mitochondrial Diseases (PMD)
January 29, 2026
·
5 min read
PMD Announces New ISIN Code and Timetable for Reverse Split of Shares
PMD Device Solutions In connection with the reverse share split, whereby 128 shares are combined into one new share, PMDS will receive a new ISIN code.
January 29, 2024
·
1 min read
Deals
Promore Pharma AB intends to carry out a reverse acquisition of PMD Device Solutions AB
Promore Pharma AB intends to acquire all the shares in PMD Device Solutions AB by making payment in the form of newly issued shares in the Company.
November 29, 2023
·
12 min read
Business
PMD – New Name and Ticker Symbol; Irish Minister To Attend Bell-Ringing Ceremony
Promore Pharma Following the reverse acquisition of Promore Pharma AB and change of name of the company from Promore Pharma AB to PMD Device Solutions AB the Company’s ticker symbol will change from PROMO to PMDS with effect from 17 January 2024.
January 16, 2024
·
2 min read
Update on Reverse Acquisition - PMD Completes Private Placement and Major Shareholder Receives Exemption from Mandatory Bid Requirements
Promore Pharma AB announced on 29 November 2023 the reverse acquisition of PMD Device Solutions AB and PMD’s intended private placement of shares in PMD prior to the Reverse Acquisition.
December 8, 2023
·
5 min read
Deals
PMD Updates on the Reverse Share Split Following the Reverse Acquisition
Device Solutions AB formerly Promore Pharma AB, carried out the reverse acquisition with the PMD group by decision of the extraordinary general meeting on 29 December 2023 and simultaneously decided on a reverse share split.
January 16, 2024
·
2 min read
Press Releases
Phoenix Molecular Designs Dosed First Patient in Dauntless-1, a Phase 2 Clinical Trial of PMD-026 in Combination with Fulvestrant for RSK2-high Breast Cancer
February 21, 2025
·
3 min read
Press Releases
OMEICOS Therapeutics Completes Enrollment of PMD-OPTION Study in Primary Mitochondrial Disease
September 26, 2024
·
3 min read
Press Releases
Agilent Showcases Next‑Generation Automated Solutions at SLAS2026
February 5, 2026
·
4 min read
Press Releases
Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
February 3, 2026
·
5 min read
1 of 19,082
Next
